Agilon Health Stock Revenue
| AGL Stock | USD 2.26 0.37 19.58% |
agilon health fundamentals help investors to digest information that contributes to Agilon Health's financial success or failures. It also enables traders to predict the movement of Agilon Stock. The fundamental analysis module provides a way to measure Agilon Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Agilon Health stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 4.3 B | 2.4 B |
Agilon | Revenue |
agilon health Company Revenue Analysis
Agilon Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Agilon Health Revenue | 4.32 B |
Most of Agilon Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, agilon health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Agilon
Projected quarterly revenue analysis of agilon health provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Agilon Health match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Agilon Health's stock price.
Agilon Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Agilon Health is extremely important. It helps to project a fair market value of Agilon Stock properly, considering its historical fundamentals such as Revenue. Since Agilon Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Agilon Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Agilon Health's interrelated accounts and indicators.
| -0.79 | -0.8 | -0.13 | -0.91 | -0.53 | ||
| -0.79 | 1.0 | 0.58 | 0.91 | 0.58 | ||
| -0.8 | 1.0 | 0.58 | 0.91 | 0.57 | ||
| -0.13 | 0.58 | 0.58 | 0.45 | 0.19 | ||
| -0.91 | 0.91 | 0.91 | 0.45 | 0.61 | ||
| -0.53 | 0.58 | 0.57 | 0.19 | 0.61 |
Click cells to compare fundamentals
Agilon Revenue Historical Pattern
Today, most investors in Agilon Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Agilon Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Agilon Health revenue as a starting point in their analysis.
Agilon Health Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Agilon Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, agilon health reported 4.32 B of revenue. This is 43.41% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 54.25% higher than that of the company.
Agilon Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Agilon Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Agilon Health could also be used in its relative valuation, which is a method of valuing Agilon Health by comparing valuation metrics of similar companies.Agilon Health is currently under evaluation in revenue category among its peers.
Agilon Health Institutional Holders
Institutional Holdings refers to the ownership stake in Agilon Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Agilon Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Agilon Health's value.| Shares | Bank Of America Corp | 2024-06-30 | 4.8 M | Charles Schwab Investment Management Inc | 2024-09-30 | 3 M | Millennium Management Llc | 2024-06-30 | 2.8 M | Northern Trust Corp | 2024-09-30 | 2.6 M | Citadel Advisors Llc | 2024-09-30 | 2.1 M | Citigroup Inc | 2024-09-30 | 2 M | Deutsche Bank Ag | 2024-06-30 | 1.8 M | Tudor Investment Corp Et Al | 2024-09-30 | 1.5 M | Aqr Capital Management Llc | 2024-06-30 | 1.4 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 112.8 M | Clayton Dubilier & Rice Llc | 2024-09-30 | 100 M |
Agilon Fundamentals
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.0984 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 429.69 M | ||||
| Shares Outstanding | 412.02 M | ||||
| Shares Owned By Insiders | 1.78 % | ||||
| Shares Owned By Institutions | 98.22 % | ||||
| Number Of Shares Shorted | 36.22 M | ||||
| Price To Earning | 23.14 X | ||||
| Price To Book | 1.35 X | ||||
| Price To Sales | 0.14 X | ||||
| Revenue | 4.32 B | ||||
| Gross Profit | 112.29 M | ||||
| EBITDA | (167.64 M) | ||||
| Net Income | (262.8 M) | ||||
| Cash And Equivalents | 497.07 M | ||||
| Cash Per Share | 2.32 X | ||||
| Total Debt | 52.31 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 2.65 X | ||||
| Book Value Per Share | 1.40 X | ||||
| Cash Flow From Operations | (156.2 M) | ||||
| Short Ratio | 8.10 X | ||||
| Earnings Per Share | (0.76) X | ||||
| Price To Earnings To Growth | 0.19 X | ||||
| Target Price | 3.63 | ||||
| Number Of Employees | 1.12 K | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 778.71 M | ||||
| Total Asset | 1.74 B | ||||
| Retained Earnings | (1.33 B) | ||||
| Working Capital | 502.92 M | ||||
| Current Asset | 1.54 B | ||||
| Current Liabilities | 2.49 B | ||||
| Net Asset | 1.74 B |
About Agilon Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze agilon health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Agilon Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of agilon health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Agilon Health Piotroski F Score and Agilon Health Altman Z Score analysis. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.951 | Earnings Share (0.76) | Revenue Per Share 13.717 | Quarterly Revenue Growth 0.276 | Return On Assets (0.1) |
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.